283 related articles for article (PubMed ID: 23542089)
21. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
[TBL] [Abstract][Full Text] [Related]
23. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus and lymphoma.
Paydas S
Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
[TBL] [Abstract][Full Text] [Related]
27. [Activation of the nuclear factor kappa B--key role in oncogenesis? Chronic hepatitis C virus infection and lymphomagenesis].
Gasztonyi B; Pár A; Kiss K; Kereskai L; Szomor A; Szeberényi J; Pajor L; Mózsik G
Orv Hetil; 2003 May; 144(18):863-8. PubMed ID: 12785239
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas.
Carloni G; Fioretti D; Rinaldi M; Ponzetto A
Crit Rev Oncol Hematol; 2019 Jun; 138():156-171. PubMed ID: 31092372
[TBL] [Abstract][Full Text] [Related]
29. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
30. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
[TBL] [Abstract][Full Text] [Related]
31. In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
Canioni D; Michot JM; Rabiega P; Molina TJ; Charlotte F; Lazure T; Davi F; Settegrana C; Berger F; Alric L; Cacoub P; Terrier B; Suarez F; Sibon D; Dupuis J; Feray C; Tilly H; Pol S; Deau Fischer B; Roulland S; Thieblemont C; Leblond V; Carrat F; Hermine O; Besson C;
PLoS One; 2016; 11(6):e0156384. PubMed ID: 27257992
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies.
Zhang W; Du F; Wang L; Bai T; Zhou X; Mei H
J Clin Transl Hepatol; 2023 Oct; 11(5):1256-1266. PubMed ID: 37577221
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C and non-Hodgkin lymphoma: the clinical perspective.
Hartridge-Lambert SK; Stein EM; Markowitz AJ; Portlock CS
Hepatology; 2012 Feb; 55(2):634-41. PubMed ID: 22120959
[TBL] [Abstract][Full Text] [Related]
34. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.
Forghieri F; Luppi M; Barozzi P; Maffei R; Potenza L; Narni F; Marasca R
Clin Dev Immunol; 2012; 2012():807351. PubMed ID: 22844326
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
[TBL] [Abstract][Full Text] [Related]
36. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.
Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F
Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.
Nicolosi Guidicelli S; Lopez-Guillermo A; Falcone U; Conconi A; Christinat A; Rodriguez-Abreu D; Grisanti S; Lobetti-Bodoni C; Piffaretti JC; Johnson PW; Mombelli G; Cerny A; Montserrat E; Cavalli F; Zucca E
Hematol Oncol; 2012 Sep; 30(3):137-42. PubMed ID: 22105737
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus - Associated marginal zone lymphoma.
Armand M; Besson C; Hermine O; Davi F
Best Pract Res Clin Haematol; 2017; 30(1-2):41-49. PubMed ID: 28288715
[TBL] [Abstract][Full Text] [Related]
39. Molecular signature in HCV-positive lymphomas.
De Re V; Caggiari L; Garziera M; De Zorzi M; Repetto O
Clin Dev Immunol; 2012; 2012():623465. PubMed ID: 22952554
[TBL] [Abstract][Full Text] [Related]
40. Viruses and cancers: possible role of hepatitis C virus.
Ferri C; La Civita L; Zignego AL; Pasero G
Eur J Clin Invest; 1997 Sep; 27(9):711-8. PubMed ID: 9352239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
